Pharmacological management of obesity improves outcomes and decreases the risk of obesity-related complications. This American Gastroenterological Association guideline is intended to support practitioners in decisions about pharmacological interventions for overweight and obesity. A multidisciplinary pa...
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
Diabetes Mellitus, Type 2,
Diabetes Mellitus,
Biomarkers/blood,
Blood Glucose/metabolism,
Diabetic Angiopathies/prevention & control,
Fructosamine/blood,
Glycated Hemoglobin/metabolism,
Hypoglycemic Agents/therapeutic use,
Life Expectancy,
Patient Preference,
Patient-Centered Care,
Glycated Hemoglobin,
Hypoglycemic Agents
"OBJECTIVE:
To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
Blood Glucose,
Combined Modality Therapy,
Diabetes Mellitus, Type 1,
Diabetes Mellitus, Type 2,
Diet, Diabetic,
Drug Monitoring,
Endocrinology,
Hyperglycemia,
Hypoglycemia,
Insulin/therapeutic use,
Insulin Infusion Systems,
Monitoring, Ambulatory,
Patient Education as Topic,
Precision Medicine,
Diabetes Mellitus, Type 1/drug therapy,
Diabetes Mellitus, Type 2/drug therapy,
Diabetes Mellitus, Type 1/therapy,
Diabetes Mellitus, Type 2/therapy,
Hypoglycemic Agents/therapeutic use,
Hypoglycemic Agents/adverse effects,
Insulin/adverse effects